Logo

Abbott's TactiCath Contact Force Ablation Catheter Receives FDA's Approval for Atrial Fibrillation (AFib)

Share this

Abbott's TactiCath Contact Force Ablation Catheter Receives FDA's Approval for Atrial Fibrillation (AFib)

Shots:

  • TactiCath is a sensor-enabled ergonomic designed catheter used for providing precise heart images while performing ablation procedures in real-time electrical activity
  • The approval leads to expansion of Abbott’s portfolio with EnSite Precision cardiac mapping system in combination with TactiCath allowing physicians to treat AFib
  • Abbott has three catheters with enabled sensors: Advisor HD Grid Mapping Catheter- FlexAbility Ablation Catheter including TactiCath which is being evaluated in 84 countries WW

   Ref: Abbott | Image:  Abbott 


Senior Editor

This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com

Share this article on WhatsApp, LinkedIn and Twitter

Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions